IGT
IGT predicts drug–target binding activity and binding poses by modeling intermolecular topological and spatial information to improve virtual screening and drug discovery.
Key Features:
- Intermolecular graph representation: Represents molecules and proteins using intermolecular graph information that captures topological and spatial relationships.
- Three-way Transformer architecture: Employs a three-way Transformer-based architecture to integrate multiple interaction pathways between ligand and receptor representations.
- Dedicated attention mechanism: Uses a dedicated attention mechanism within the architecture to explicitly model intermolecular interactions.
- Joint activity and pose prediction: Produces predictions for both binding activity and binding pose for drug–target pairs.
- Improved predictive performance: Outperforms the second-best available models by 9.1% for binding activity prediction and by 20.5% for binding pose prediction.
- Generalization to unseen receptors: Demonstrates superior generalization when applied to unseen receptor proteins.
- Experimental validation (SARS-CoV-2): Identified active compounds against SARS-CoV-2 with 83.1% of predicted actives validated by wet-lab experiments and predicted poses closely matching native configurations.
Scientific Applications:
- Virtual screening: Prioritizes candidate compounds for virtual screening workflows in drug discovery.
- Binding activity prediction: Predicts ligand–receptor binding activity to support lead selection and prioritization.
- Binding pose prediction: Predicts binding poses to inform structure-based design and hypothesis generation.
- Discovery for emerging pathogens: Enables identification and prioritization of active compounds against targets such as SARS-CoV-2 for experimental follow-up.
Methodology:
Models intermolecular graphs using a three-way Transformer-based architecture with a dedicated attention mechanism to capture topological and spatial intermolecular interactions for joint binding activity and pose prediction.
Topics
Details
- License:
- MIT
- Cost:
- Free of charge
- Tool Type:
- command-line tool
- Programming Languages:
- Python
- Added:
- 8/28/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Liu S, Wang Y, Deng Y, He L, Shao B, Yin J, Zheng N, Liu T, Wang T. Improved drug–target interaction prediction with intermolecular graph transformer. Briefings in Bioinformatics. 2022;23(5). doi:10.1093/bib/bbac162. PMID:35514186.
DOI: 10.1093/bib/bbac162
PMID: 35514186
Funding: - National Natural Science Foundation of China: U1711261, U1711262, U1811261, U1811264, U1911203, U2001211
- Guangdong Basic and Applied Basic Research Foundation: 2019B1515130001
- Key Research and Development Program of Guangdong Province: 2018B010107005